Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ANGPTL4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GUK1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EIF3K - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DZIP3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TOMM70 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ACTG2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TINAGL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
AAK1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PDLIM7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PSMC5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PCNX1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BTN3A3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ADA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
WDR13 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
NCAPH2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZMAT3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BPHL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CTAG2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on